pharma news

News

Neuralink rival Paradromics cleared to start speech trial

Brain computer interface developer Paradromics has been cleared to start a US clinical trial of its Connexus implant for speech restoration.

News

Alnylam's ATTR cardiomyopathy drug backed for NHS use

Patients with ATTR-CM in England and Wales will soon have a new treatment option, after NICE backed use of Alnylam's three-month injectable Amvuttra.

News

ADC specialist Solve raises $120m, and other biofinancings

Our round-up of biofinancings is led by a $120m round for ADC specialist Solve, with Aspen, Artios, Profluent, and Gate Bioscience also raising funds.

News

Gloved hand punches a karate pad held up

GSK unit and AnaptysBio trade lawsuits over Jemperli

A spat between GSK/Tesaro and AnaptysBio over cancer drug Jemperli has escalated into litigation, with both parties claiming breach of contract.

News

NICE backs five AI tools for bowel cancer screening

Five AI technologies used during a colonoscopy exam to help detect the early signs of bowel cancer have been backed for use by the NHS in England.

News

Merck partners Valo on $3bn, AI-based Parkinson's project

Merck has teamed up with Valo Health on a project to apply AI to the discovery of novel drug targets and drugs for Parkinson's.

Neuralink rival Paradromics cleared to start speech trial

Alnylam's ATTR cardiomyopathy drug backed for NHS use

ADC specialist Solve raises $120m, and other biofinancings

GSK unit and AnaptysBio trade lawsuits over Jemperli

NICE backs five AI tools for bowel cancer screening

Merck partners Valo on $3bn, AI-based Parkinson's project

EU clears first drug therapy for rare disease cALD

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks